United States · FDA National Drug Code directory

DICLEGIS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 55494-100_19a108be-4aba-4906-8a5d-35f5b263b1c2
Product NDC: 55494-100
Form: TABLET, DELAYED RELEASE
Composition / generic term: doxylamine succinate and pyridoxine hydrochloride
Labeler: Duchesnay USA, Inc.
Marketing category: NDA
Marketing start / end (source format): 20130515
Source listing expiry: 20261231

Source-listed ingredients

DOXYLAMINE SUCCINATE — 10 mg/1
PYRIDOXINE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, DELAYED RELEASE in 1 BOTTLE (55494-100-10) · 55494-100-10
12 TABLET, DELAYED RELEASE in 1 BOTTLE (55494-100-99) · 55494-100-99

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →